NEIDirector Profile Banner
Michael F. Chiang, MD Profile
Michael F. Chiang, MD

@NEIDirector

Followers
9K
Following
42K
Statuses
2K

This is the official Twitter account of Michael F. Chiang, MD, Director of the @NatEyeInstitute @NIH. Tweets, retweets & follows are not endorsements.

Bethesda, MD
Joined March 2021
Don't wanna be here? Send us removal request.
@NEIDirector
Michael F. Chiang, MD
3 years
In Blade Runner, “seeking answers was all about looking at the eyes”. At @NatEyeInstitute, we totally agree. If you’re interested in #vision, #research, grant funding, #Ophthalmology, or #Optometry: follow this feed. (I’ll also post about #informatics and #DataScience.) (1/3)
Tweet media one
16
31
238
@NEIDirector
Michael F. Chiang, MD
19 days
Good news for #myopia therapy: Multifocal contact lens treatment slows axial eye growth, without rebound effect after discontinuing treatment. #NEIfunded work from @OhioStateEye @UHouston @JAMAOphth:
Tweet media one
1
4
22
@NEIDirector
Michael F. Chiang, MD
23 days
Lessons from the lamprey fish. The primitive jawless vertebrate whose ancestors diverged from all other vertebrates over 500 million years ago, offers a window into the origins of mammalian retina formation. #NEIfunded @NatureComms
Tweet media one
2
0
8
@NEIDirector
Michael F. Chiang, MD
24 days
High-efficiency base editing to treat #Stargardt disease looks promising in primates and human tissue #organoids. @UniBasel_en @NatureMedicine:
Tweet media one
0
7
13
@NEIDirector
Michael F. Chiang, MD
25 days
Current wearable haptic devices underutilize the skin's perceptual capabilities. Interesting design concept for cutaneous electrohydraulic (CUTE) devices aimed at providing a range of cues. @MPIforBI @WileyGlobal:
Tweet media one
1
1
3
@NEIDirector
Michael F. Chiang, MD
25 days
#NEIfunded IRIS registry study: Predictors of health care disparities in Fuchs treatment Age, sex, race, ethnicity & insurance factor into surgical interventions for FECD. @UW @NIHAging @aaronylee @CorneaJournal:
Tweet media one
0
0
2
@NEIDirector
Michael F. Chiang, MD
25 days
At @NIH: sponsoring a $1M Data Sharing Index Challenge to develop a metric for assessing how effectively researchers share useful data. Can use to build culture of open/team science. Webinar (Tues 1/28/25, 12pm ET): Challenge Info:
Tweet media one
1
4
7
@NEIDirector
Michael F. Chiang, MD
26 days
Funding opportunity: Does your research focus on preventing, reducing or eliminating disparities in eye and vision health? @NatEyeInstitute & @NIMHD are seeking applications addressing vision health and #SDOH Apply by 3/3/25:
Tweet media one
0
0
0
@NEIDirector
Michael F. Chiang, MD
26 days
Major new @NIH funding opportunity in new approach methodologies: Coordinating Center & Data Hub for the @NIH_CommonFund #ComplementARIE program Details:
Tweet media one
1
2
5
@NEIDirector
Michael F. Chiang, MD
27 days
Today at noon ET for @NatEyeInstitute Retinal Disease Interest Group Seminar: Petr Baranov: "Guiding Donor Cells to Their Fate: The Role of Retinal Optic Nerve Microenvironment in Cell Replacement" @BaranovLab @HMSeye @MassEyeAndEar Details:
Tweet media one
0
2
8
@NEIDirector
Michael F. Chiang, MD
30 days
1/10, 12-1pm ET: @NatEyeInstitute's Retinal Disease Interest Group: Petr Baranov, MD, PhD "Guiding Donor Cells to Their Fate: The Role of Retinal Optic Nerve Microenvironment in Cell Replacement" @BaranovLab @HMSeye @MassEyeAndEar @harvardmed Details:
Tweet media one
0
0
2
@NEIDirector
Michael F. Chiang, MD
1 month
#NEIfunded longitudinal study reveals disparities in perimetry test-retest variability that may delay detecting glaucoma progression among Black or African American and Hispanic or Latino populations. @BascomPalmerEye @grdslab @SciReports:
Tweet media one
0
2
4
@NEIDirector
Michael F. Chiang, MD
1 month
Funding opportunity: Does your research focus on preventing, reducing or eliminating disparities in eye and vision health? @NatEyeInstitute & @NIMHD are seeking applications addressing vision health and #SDOH #RequestforApplications Apply by 3/3/25:
Tweet media one
0
3
3
@NEIDirector
Michael F. Chiang, MD
1 month
Excited to announce Dr. Farran Briggs will join @NatEyeInstitute as Senior Investigator in the Laboratory of Sensorimotor Research. Most recently at @UofR, Briggs brings an impressive record of #optogenetics & functional ultrasound research, charismatic training & mentoring.
Tweet media one
1
10
41
@NEIDirector
Michael F. Chiang, MD
1 month
A @NatEyeInstitute intramural study adds a twist on how the widely used cell death marker, annexin-V, can be interpreted in the lab & clinic for tracking retinal cell death in eye diseases such as glaucoma. @WeiLilab @IRPatNIH @MDPIOpenAccess:
Tweet media one
0
1
10
@NEIDirector
Michael F. Chiang, MD
1 month
Study of sub-Tenon triamcinolone in a nonuveitic and nonsurgical pediatric population: no patients required IOP-lowering medications or glaucoma surgery. @MassEyeAndEar @HMSeye @harvardmed @BascomPalmerEye @RetinaJournal:
Tweet media one
0
2
4
@NEIDirector
Michael F. Chiang, MD
1 month
Who's at risk for DR progression? Post hoc analysis: Predominantly peripheral lesions on ultrawide field fluorescein angiography is associated with significantly increased risk of DR worsening. #NEIfunded @DrcrNet @RetinaJournal:
Tweet media one
0
2
5
@NEIDirector
Michael F. Chiang, MD
1 month
Early blood flow changes in diabetic retinopathy (DR)? Variable interscan time analysis - a computational technique to characterize blood flow speed in OCTA - measures alterations in DR vs normal eyes. #NEIfunded @TuftsMedicine @MITEECS @RetinaJournal:
Tweet media one
0
2
10
@NEIDirector
Michael F. Chiang, MD
1 month
From @ICHF_PAN (Poland): an imaging technique that allows the visualization of microcirculatory systems & blood flow in individual layers of the retina. @SPIEtweets #Neurophotonics:
Tweet media one
1
5
14
@NEIDirector
Michael F. Chiang, MD
1 month
From @nyuniversity: a new miniaturized haptic feedback backpack device helps people with low vision navigate public transport in NYC. @nyutandon @jrrizzo00 @PorfiriMaurizio @MTA
Tweet media one
0
2
7
@NEIDirector
Michael F. Chiang, MD
2 months
From @SyddanskUni (Denmark): study confirms an early American report that Ozempic doubles the risk of NAION in people with type 2 #diabetes. Overall risk still low (1/50,000) but something to keep an eye on. @JakobGrauslund @Pottegard @BioMedCentral:
Tweet media one
0
2
9